Biomarkers as a tool for management of immunosuppression in transplant patients

Therapeutic drug monitoring is a well-established approach in transplantation medicine to guide immunosuppressive therapy. However, it cannot always predict the effects of immunosuppressive drugs on immune cells, because it does not reflect any aspect of an individual patient's immune system. P...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wieland, Eberhard (VerfasserIn) , Olbricht, Christoph J. (VerfasserIn) , Süsal, Caner (VerfasserIn) , Gurragchaa, Purevtseren (VerfasserIn) , Böhler, Torsten (VerfasserIn) , Israeli, Moshe (VerfasserIn) , Sommerer, Claudia (VerfasserIn) , Budde, Klemens (VerfasserIn) , Hartmann, Bertram Josef (VerfasserIn) , Shipkova, Maria (VerfasserIn) , Oellerich, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: [October 2010]
In: Therapeutic drug monitoring
Year: 2010, Jahrgang: 32, Heft: 5, Pages: 560-572
ISSN:1536-3694
DOI:10.1097/FTD.0b013e3181efb3d2
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/FTD.0b013e3181efb3d2
Verlag, lizenzpflichtig, Volltext: https://journals.lww.com/drug-monitoring/fulltext/2010/10000/biomarkers_as_a_tool_for_management_of.6.aspx
Volltext
Verfasserangaben:Eberhard Wieland, Christoph J. Olbricht, Caner Süsal, Purevtseren Gurragchaa, Torsten Böhler, Moshe Israeli, Claudia Sommerer, Klemens Budde, Bertram Hartmann, Maria Shipkova, and Michael Oellerich

MARC

LEADER 00000caa a2200000 c 4500
001 1879469758
003 DE-627
005 20240311115857.0
007 cr uuu---uuuuu
008 240129s2010 xx |||||o 00| ||eng c
024 7 |a 10.1097/FTD.0b013e3181efb3d2  |2 doi 
035 |a (DE-627)1879469758 
035 |a (DE-599)KXP1879469758 
035 |a (OCoLC)1425872356 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wieland, Eberhard  |e VerfasserIn  |0 (DE-588)1279743174  |0 (DE-627)1832918734  |4 aut 
245 1 0 |a Biomarkers as a tool for management of immunosuppression in transplant patients  |c Eberhard Wieland, Christoph J. Olbricht, Caner Süsal, Purevtseren Gurragchaa, Torsten Böhler, Moshe Israeli, Claudia Sommerer, Klemens Budde, Bertram Hartmann, Maria Shipkova, and Michael Oellerich 
264 1 |c [October 2010] 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 29.01.2024 
520 |a Therapeutic drug monitoring is a well-established approach in transplantation medicine to guide immunosuppressive therapy. However, it cannot always predict the effects of immunosuppressive drugs on immune cells, because it does not reflect any aspect of an individual patient's immune system. Pharmacodynamic monitoring is a more recent strategy to provide information about the biologic effect of a specific drug or drug combination on the individual transplant patient. Currently, there is a large number of different biomarkers that either directly (specific markers) or indirectly (global markers) relate to the pharmacodynamic effects of immunosuppressive drugs and are under investigation as potential candidates to be introduced in clinical practice. Such biomarkers may be useful to identify patients at risk of developing acute rejection, infection, or cancer as well as patients who are suitable for minimization of immunosuppressant therapy and may be helpful to manage the timing and rate of immunosuppressant weaning. Serial longitudinal monitoring may allow maintenance of an individualized immunosuppressive regimen. Thus, biomarker monitoring is a potential complementary tool to therapeutic drug monitoring. This review summarizes the current state of knowledge about the use of a number of global or drug-specific pharmacodynamic biomarkers. It is not a comprehensive overview of the literature available, but rather an evidence-based reflection by experts who are intensively involved in scientific work in this field. 
700 1 |a Olbricht, Christoph J.  |e VerfasserIn  |4 aut 
700 1 |a Süsal, Caner  |e VerfasserIn  |0 (DE-588)102648037X  |0 (DE-627)726772763  |0 (DE-576)37182673X  |4 aut 
700 1 |a Gurragchaa, Purevtseren  |e VerfasserIn  |4 aut 
700 1 |a Böhler, Torsten  |e VerfasserIn  |4 aut 
700 1 |a Israeli, Moshe  |e VerfasserIn  |4 aut 
700 1 |a Sommerer, Claudia  |d 1971-  |e VerfasserIn  |0 (DE-588)121857654  |0 (DE-627)705680002  |0 (DE-576)292921829  |4 aut 
700 1 |a Budde, Klemens  |e VerfasserIn  |4 aut 
700 1 |a Hartmann, Bertram Josef  |d 1965-  |e VerfasserIn  |0 (DE-588)120600749  |0 (DE-627)704864827  |0 (DE-576)292294840  |4 aut 
700 1 |a Shipkova, Maria  |e VerfasserIn  |4 aut 
700 1 |a Oellerich, Michael  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Therapeutic drug monitoring  |d Philadelphia, Pa. : Lippincott Williams & Wilkins, 1979  |g 32(2010), 5 vom: Okt., Seite 560-572  |h Online-Ressource  |w (DE-627)330079239  |w (DE-600)2048919-5  |w (DE-576)094529795  |x 1536-3694  |7 nnas  |a Biomarkers as a tool for management of immunosuppression in transplant patients 
773 1 8 |g volume:32  |g year:2010  |g number:5  |g month:10  |g pages:560-572  |g extent:13  |a Biomarkers as a tool for management of immunosuppression in transplant patients 
856 4 0 |u https://doi.org/10.1097/FTD.0b013e3181efb3d2  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://journals.lww.com/drug-monitoring/fulltext/2010/10000/biomarkers_as_a_tool_for_management_of.6.aspx  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20240129 
993 |a Article 
994 |a 2010 
998 |g 121857654  |a Sommerer, Claudia  |m 121857654:Sommerer, Claudia  |d 910000  |d 910100  |e 910000PS121857654  |e 910100PS121857654  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 102648037X  |a Süsal, Caner  |m 102648037X:Süsal, Caner  |d 910000  |d 911600  |d 50000  |e 910000PS102648037X  |e 911600PS102648037X  |e 50000PS102648037X  |k 0/910000/  |k 1/910000/911600/  |k 0/50000/  |p 3 
999 |a KXP-PPN1879469758  |e 4472016176 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Eberhard Wieland, Christoph J. Olbricht, Caner Süsal, Purevtseren Gurragchaa, Torsten Böhler, Moshe Israeli, Claudia Sommerer, Klemens Budde, Bertram Hartmann, Maria Shipkova, and Michael Oellerich"]},"physDesc":[{"extent":"13 S."}],"recId":"1879469758","relHost":[{"id":{"issn":["1536-3694"],"eki":["330079239"],"zdb":["2048919-5"]},"pubHistory":["1.1979 -"],"recId":"330079239","physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"title":[{"title":"Therapeutic drug monitoring","subtitle":"official journal of the International Association of Therapeutic Drug Monitoring and Clinical Toxicology","title_sort":"Therapeutic drug monitoring"}],"note":["Gesehen am 11.06.2019"],"origin":[{"dateIssuedKey":"1979","publisher":"Lippincott Williams & Wilkins ; Ovid","publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar]","dateIssuedDisp":"1979-"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"part":{"issue":"5","extent":"13","volume":"32","year":"2010","text":"32(2010), 5 vom: Okt., Seite 560-572","pages":"560-572"},"disp":"Biomarkers as a tool for management of immunosuppression in transplant patientsTherapeutic drug monitoring"}],"id":{"doi":["10.1097/FTD.0b013e3181efb3d2"],"eki":["1879469758"]},"person":[{"given":"Eberhard","role":"aut","family":"Wieland","display":"Wieland, Eberhard"},{"family":"Olbricht","display":"Olbricht, Christoph J.","given":"Christoph J.","role":"aut"},{"role":"aut","given":"Caner","family":"Süsal","display":"Süsal, Caner"},{"display":"Gurragchaa, Purevtseren","family":"Gurragchaa","role":"aut","given":"Purevtseren"},{"given":"Torsten","role":"aut","display":"Böhler, Torsten","family":"Böhler"},{"family":"Israeli","display":"Israeli, Moshe","given":"Moshe","role":"aut"},{"display":"Sommerer, Claudia","family":"Sommerer","given":"Claudia","role":"aut"},{"display":"Budde, Klemens","family":"Budde","given":"Klemens","role":"aut"},{"role":"aut","given":"Bertram Josef","display":"Hartmann, Bertram Josef","family":"Hartmann"},{"family":"Shipkova","display":"Shipkova, Maria","role":"aut","given":"Maria"},{"role":"aut","given":"Michael","family":"Oellerich","display":"Oellerich, Michael"}],"title":[{"title_sort":"Biomarkers as a tool for management of immunosuppression in transplant patients","title":"Biomarkers as a tool for management of immunosuppression in transplant patients"}],"note":["Gesehen am 29.01.2024"],"origin":[{"dateIssuedKey":"2010","dateIssuedDisp":"[October 2010]"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"]} 
SRT |a WIELANDEBEBIOMARKERS2010